Jeffrey Farrow

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Jeffrey Farrow
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey Farrow:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tarsus Pharmaceuticals, Inc. Chief Financial Officer and Chief Strategy Officer Common Stock 36,704 $1,483,575 $40.42 17 Jun 2025 Direct
Tarsus Pharmaceuticals, Inc. Chief Financial Officer and Chief Strategy Officer Stock Option (right to buy) 30,628 $336,602 $10.99 05 Mar 2025 Direct
Tarsus Pharmaceuticals, Inc. Chief Financial Officer and Chief Strategy Officer Restricted Stock Units 55,763 $310,133 $12.89 16 Jun 2025 Direct
Global Blood Therapeutics, Inc. Chief Financial Officer Common Stock 0 $46.99 05 Oct 2022 Direct
Global Blood Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 0 05 Oct 2022 Direct
Global Blood Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 0 05 Oct 2022 Direct

Insider Reports Filed by Jeffrey Farrow

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TARS Tarsus Pharmaceuticals, Inc. 16 Jun 2025 3 -$550,035 4 Chief Financial Officer and Chief Strategy Officer 18 Jun 2025, 16:07
TARS Tarsus Pharmaceuticals, Inc. 18 Mar 2025 3 -$178,306 4 Chief Financial Officer and Chief Strategy Officer 20 Mar 2025, 21:48
TARS Tarsus Pharmaceuticals, Inc. 15 Mar 2025 2 $0 4 Chief Financial Officer and Chief Strategy Officer 18 Mar 2025, 21:40
TARS Tarsus Pharmaceuticals, Inc. 05 Mar 2025 2 $0 4 Chief Financial Officer and Chief Strategy Officer 07 Mar 2025, 16:19
TARS Tarsus Pharmaceuticals, Inc. 17 Jun 2024 3 -$286,924 4 Chief Financial Officer and Chief Strategy Officer 20 Jun 2024, 16:26
TARS Tarsus Pharmaceuticals, Inc. 07 Mar 2024 2 $0 4 Chief Financial Officer and Chief Strategy Officer 11 Mar 2024, 17:11
TARS Tarsus Pharmaceuticals, Inc. 24 Apr 2023 0 $0 3/A Chief Financial Officer and Chief Strategy Officer Exhibit 24 - Power of Attorney 28 Apr 2023, 20:01
TARS Tarsus Pharmaceuticals, Inc. 24 Apr 2023 2 $0 4 Chief Financial Officer and Chief Strategic Officer 26 Apr 2023, 17:05
/report/000089924322033145-farrow-jeffrey-s-2022-10-05 Global Blood Therapeutics, Inc. 05 Oct 2022 14 $0 4 Chief Financial Officer 06 Oct 2022, 16:15
/report/000089924322032265-farrow-jeffrey-s-2022-09-27 Global Blood Therapeutics, Inc. 27 Sep 2022 2 +$387,909 4 Chief Financial Officer 29 Sep 2022, 20:48
/report/000089924322030475-farrow-jeffrey-s-2022-09-01 Global Blood Therapeutics, Inc. 01 Sep 2022 6 -$2,266,451 4 Chief Financial Officer 06 Sep 2022, 19:00
/report/000089924322027634-farrow-jeffrey-s-2022-08-01 Global Blood Therapeutics, Inc. 01 Aug 2022 4 -$68,882 4 Chief Financial Officer 03 Aug 2022, 18:00
/report/000089924322009239-farrow-jeffrey-s-2022-03-01 Global Blood Therapeutics, Inc. 01 Mar 2022 6 -$39,279 4 Chief Financial Officer 03 Mar 2022, 19:52
/report/000089924322004639-farrow-jeffrey-s-2022-02-01 Global Blood Therapeutics, Inc. 01 Feb 2022 5 -$132,161 4 Chief Financial Officer 03 Feb 2022, 16:49
/report/000089924321035221-farrow-jeffrey-s-2021-09-01 Global Blood Therapeutics, Inc. 01 Sep 2021 3 -$40,894 4 Chief Financial Officer 03 Sep 2021, 20:00
/report/000089924321037668-farrow-jeffrey-s-2021-08-01-restatement Global Blood Therapeutics, Inc. 01 Aug 2021 5 -$118,995 4/A Chief Financial Officer 24 Sep 2021, 19:00